Immunology
-
An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization
This article has 8 authors:Reviewed by ScreenIT
-
Impaired immune response drives age-dependent severity of COVID-19
This article has 20 authors:Reviewed by ScreenIT
-
Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection
This article has 20 authors:Reviewed by ScreenIT
-
Vγ9Vδ2 T cells are potent inhibitors of SARS-CoV-2 replication and exert effector phenotypes in COVID-19 patients
This article has 15 authors:Reviewed by ScreenIT
-
Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model
This article has 19 authors:Reviewed by ScreenIT
-
Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice
This article has 12 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
BCG vaccination of Diversity Outbred mice induces cross-reactive antibodies to SARS-CoV-2 spike protein
This article has 5 authors:Reviewed by ScreenIT
-
An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models
This article has 18 authors:Reviewed by ScreenIT
-
Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein
This article has 15 authors:Reviewed by ScreenIT
-
The SARS-CoV-2 Omicron BA.1 spike G446S potentiates HLA-A*24:02-restricted T cell immunity
This article has 13 authors:Reviewed by ScreenIT